Showing items 101–138
Modified nucleosides, nucleotides, and nucleic acids, and uses thereof
Grant US-9334328-B2
United States of America
MRNA therapy for Fabry disease
Grant US-9308281-B2
United States of America
Modified polynucleotides encoding apoptosis inducing factor 1
Grant US-9301993-B2
United States of America
Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins
Grant US-9303079-B2
United States of America
Formulation and delivery of PLGA microspheres
Grant US-9295689-B2
United States of America
Modified polynucleotides for the production of nuclear proteins
Grant US-9283287-B2
United States of America
Formulation and delivery of PLGA microspheres
Grant US-9271996-B2
United States of America
Modified polynucleotides encoding SIAH E3 ubiquitin protein ligase 1
Grant US-9255129-B2
United States of America
Modified polynucleotides for the production of proteins
Grant US-9254311-B2
United States of America
Modified polynucleotides for the production of proteins associated with blood and…
Grant US-9233141-B2
United States of America
In vivo production of proteins
Grant US-9221891-B2
United States of America
Modified polynucleotides encoding aquaporin-5
Grant US-9220792-B2
United States of America
Modified polynucleotides for the production of proteins associated with blood and…
Grant US-9220755-B2
United States of America
Modified polynucleotides encoding granulysin
Grant US-9216205-B2
United States of America
Modified polynucleotides for the production of secreted proteins
Grant US-9192651-B2
United States of America
Split dose administration
Grant US-9186372-B2
United States of America
Engineered nucleic acids and methods of use thereof
Grant US-9181319-B2
United States of America
CFTR mRNA compositions and related methods and uses
Grant US-9181321-B2
United States of America
Modified polynucleotides encoding septin-4
Grant US-9149506-B2
United States of America
Modified polynucleotides encoding citeD4
Grant US-9114113-B2
United States of America
Modified polynucleotides encoding basic helix-loop-helix family member E41
Grant US-9107886-B2
United States of America
Modified polynucleotides encoding copper metabolism (MURR1) domain containing 1
Grant US-9095552-B2
United States of America
Modified polynucleotides for treating galactosylceramidase protein deficiency
Grant US-9089604-B2
United States of America
mRNA for use in treatment of human genetic diseases
Grant US-9061021-B2
United States of America
Modified polynucleotides for treating protein deficiency
Grant US-9061059-B2
United States of America
Modified polynucleotides encoding aryl hydrocarbon receptor nuclear translocator
Grant US-9050297-B2
United States of America
Modified polynucleotides for the production of biologics and proteins associated with…
Grant US-8999380-B2
United States of America
Compositions and methods of altering cholesterol levels
Grant US-8980864-B2
United States of America
mRNA for use in treatment of human genetic diseases
Grant US-8853377-B2
United States of America
SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES
Application WO-2014113089-A3
World Intellectual Property Organisation (WIPO)
Engineered nucleic acids and methods of use thereof
Grant US-8822663-B2
United States of America
DLIN-KC2-DMA lipid nanoparticle delivery of modified polynucleotides
Grant US-8754062-B2
United States of America
Engineered nucleic acids encoding a modified erythropoietin and their expression
Grant US-8710200-B2
United States of America
Modified polynucleotides for the production of G-CSF
Grant US-8680069-B2
United States of America
Method for producing a protein of interest in a primate
Grant US-8664194-B2
United States of America
IN VIVO PRODUCTION OF PROTEINS
Application WO-2013151736-A3
World Intellectual Property Organisation (WIPO)
PHARMACEUTICAL COMPOSITION CONSISTING OF RNA HAVING ALKALI METAL AS COUNTER ION AND…
Application WO-2012103985-A2
World Intellectual Property Organisation (WIPO)
Showing items 101–138